Analyst Reco. Zymeworks Inc.

Equities

ZYME

US98985Y1082

Real-time Estimate Cboe BZX Other stock markets 12:35:10 2024-05-01 pm EDT			5-day change	1st Jan Change
8.73 ^USD	+1.75%		+2.11%	-15.98%

Apr. 08	Zymeworks Inc. Presents New Data from Multiple Preclinical Development Programs At 2024 American Association for Cancer Research Annual Meeting	CI
Apr. 04	Zymeworks Inc. Removes Christopher Astle from the Positions of Chief Financial Officer	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wells Fargo Adjusts Price Target on Zymeworks to $14 From $12, Maintains Overweight Rating	Mar. 12	MT
H.C. Wainwright Adjusts Price Target on Zymeworks to $10 From $8, Maintains Neutral Rating	Mar. 11	MT
Citigroup Adjusts Price Target on Zymeworks to $18 From $17, Keeps Buy Rating	23-05-18	MT
Stifel Adjusts Price Target on Zymeworks to $19 From $18, Maintains Buy Rating	23-05-09	MT
JPMorgan Raises Zymeworks' Price Target to $9 From $8, Keeps Neutral Rating	23-03-31	MT
Wells Fargo Raises Price Target for Zymeworks to $12 From $9, Maintains Overweight Rating	23-02-13	MT
SVB Securities Raises Price Target on Zymeworks to $10 From $8, Maintains Market Perform Rating	23-01-20	MT
HC Wainwright Adjusts Price Target on Zymeworks to $8 From $10, Maintains Neutral Rating	23-01-04	MT
Barclays Adjusts Zymeworks Price Target to $9 From $7, Maintains Equal Weight Rating	22-12-22	MT
Jefferies Upgrades Zymeworks to Buy From Hold, Adjusts Price Target to $11 From $7.70	22-12-20	MT
HC Wainwright Adjusts Price Target on Zymeworks to $10 From $8, Maintains Neutral Rating	22-11-21	MT
HC Wainwright Downgrades Zymeworks to Neutral From Buy, Lowers Price Target to $8 From $40	22-11-01	MT
Stifel Adjusts Zymeworks' Price Target to $18 From $21, Reiterates Buy Rating	22-10-24	MT
SVB Securities Downgrades Zymeworks to Market Perform From Outperform, Adjusts Price Target to $8 From $19	22-10-21	MT
Citigroup Lowers Zymeworks Price Target to $21 From $27, Maintains Buy Rating	22-09-13	MT
Citigroup Trims Price Target on Zymeworks to $27 From $28, Reiterates Buy Rating	22-08-29	MT
SVB Securities Adjusts Zymeworks' Price Target to $19 from $18, Keeps Outperform Rating	22-05-27	MT
HC Wainwright Adjusts Zymeworks' Price Target to $40 from $44, Keeps Buy Rating	22-05-23	MT
Citigroup Lowers Zymeworks Price Target to $28 From $30, Buy Rating Kept	22-05-09	MT
Guggenheim Upgrades Zymeworks to Buy From Neutral; Price Target is $14	22-05-05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Zymeworks Inc.

Equities

ZYME

US98985Y1082

Analyst Reco.

Filters